San Jose, CA, United States of America

Evan Matthew Bishop

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Evan Matthew Bishop

Introduction

Evan Matthew Bishop is an accomplished inventor based in San Jose, California. He has made significant contributions to the field of biotechnology, particularly in the development of multi-specific antibodies for cancer treatment. His innovative work has the potential to enhance therapeutic options for patients suffering from cancer.

Latest Patents

Evan holds a patent for "Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto." This patent provides multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen. The invention includes pharmaceutical compositions, nucleic acids, recombinant expression vectors, cells, and kits that incorporate or encode these multi-specific antibodies. Additionally, the patent outlines methods for treating cancer by administering these antibodies to patients, as well as methods for generating the antibodies and related reagents.

Career Highlights

Evan is associated with the William Robert Arathoon Living Trust Dated August 29, 2016. His work in this organization has allowed him to focus on innovative research and development in the field of cancer therapeutics. His dedication to advancing medical science is evident in his patent and ongoing research efforts.

Collaborations

Evan collaborates with notable colleagues, including William Robert Arathoon and Raffaella Briante. Their combined expertise contributes to the success of their projects and enhances the potential impact of their innovations.

Conclusion

Evan Matthew Bishop is a notable inventor whose work in multi-specific antibodies represents a significant advancement in cancer treatment. His contributions to biotechnology continue to pave the way for new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…